Top Drugs Losing Patent Exclusivity in 2021

Published date29 April 2021
Subject MatterPatents,Biotechnology,Patent Litigation,Pharmaceutical Patents,Pharmaceutical Industry,Prescription Drugs,Life Sciences,Abbreviated New Drug Application (ANDA),Generic Drugs
AuthorKevin Noonan
Law FirmMcDonnell Boehnen Hulbert & Berghoff LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT